Secondary genetic factors in cystic fibrosis lung disease

被引：7

作者：

Mahadeva, R ^{[1
]}

Lomas, DA ^{[1
]}

机构：

[1] Univ Cambridge, Wellcome Trust Ctr Mol Mechanisms Dis, Inst Med Res, Dept Med,Resp Med Unit, Cambridge CB2 2XY, England

来源：

关键词：

D O I：

10.1136/thorax.55.6.446

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页码：446 / 446

页数：1

共 50 条

[41] Emerging therapies for cystic fibrosis lung disease
Rubin, BK
CHEST, 1999, 115 (04) : 1120 - 1126
[42] PERFUSION MRI IN CYSTIC FIBROSIS LUNG DISEASE
Wielpuetz, Mark O.
PEDIATRIC PULMONOLOGY, 2017, 52 : S204 - S204
[43] Antioxidant supplementation for lung disease in cystic fibrosis
Ciofu, Oana
Lykkesfeldt, Jens
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (08):
[44] Innate immunity in cystic fibrosis lung disease
Hartl, D.
Gaggar, A.
Bruscia, E.
Hector, A.
Marcos, V.
Jung, A.
Greene, C.
McElvaney, G.
Mall, M.
Doering, G.
JOURNAL OF CYSTIC FIBROSIS, 2012, 11 (05) : 363 - 382
[45] Cystic fibrosis lung disease in adult patients
Vender, Robert L.
POSTGRADUATE MEDICINE, 2008, 120 (01) : 64 - 74
[46] Lung disease modifier genes in cystic fibrosis
Guillot, Loic
Beucher, Julie
Tabary, Olivier
Le Rouzic, Philippe
Clement, Annick
Corvol, Harriet
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2014, 52 : 83 - 93
[47] Cystic Fibrosis Lung Disease in the Aging Population
Kunzi, Lisa
Easter, Molly
Hirsch, Meghan June
Krick, Stefanie
FRONTIERS IN PHARMACOLOGY, 2021, 12
[48] Identifying the Origins of Cystic Fibrosis Lung Disease
Davis, Stephanie D.
Ferkol, Thomas
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (21): : 2026 - 2028
[49] Hydrator therapies for cystic fibrosis lung disease
Donaldson, Scott H.
PEDIATRIC PULMONOLOGY, 2008, 43 (09) : S18 - S23
[50] The evolution of lung disease in children with cystic fibrosis
Le Bourgeois, M.
ARCHIVES DE PEDIATRIE, 2009, 16 (06): : 576 - 577